New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2013
10:01 EDTAHS, MDU, ZMH, IRWD, PRO, WU, UTIW, PL, PM, NNA, MOH, GRPN, CMCSA, BPLOn the Fly: Analyst Upgrade Summary
Today’s noteworthy upgrades include: AMN Healthcare (AHS) upgraded to Buy from Neutral at SunTrust... Avon Products (AVP) upgraded to Neutral from Sell at UBS... Comcast (CMCSA) upgraded to Outperform from Neutral at Credit Suisse... Groupon (GRPN) upgraded to Buy from Neutral at Sterne Agee... Molina Healthcare (MOH) upgraded to Buy from Neutral at BofA/Merrill... Navios Acquisition (NNA) upgraded to Outperform from Market Perform at Wells Fargo... Philip Morris (PM) upgraded to Neutral from Reduce at Nomura... Protective Life (PL) upgraded to Neutral from Underperform at BofA/Merrill... UTi Worldwide (UTIW) upgraded to Buy from Hold at Jefferies... Western Union (WU) upgraded to Underperform from Sell at CLSA... Avon Products (AVP) upgraded to Buy from Neutral at B. Riley Caris... PROS (PRO) upgraded to Buy from Hold at Craig-Hallum... Western Union (WU) upgraded to Neutral from Sell at Compass Point... Ironwood (IRWD) upgraded to Neutral from Underperform at Wedbush... Zimmer (ZMH) upgraded to Buy from Hold at Argus... Buckeye Partners (BPL) upgraded to Buy from Hold at Argus... MDU Resources (MDU) upgraded to Buy from Hold at Williams Capital.
News For AHS;CMCSA;GRPN;MOH;NNA;PM;PL;UTIW;WU;PRO;IRWD;ZMH;MDU;BPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 21, 2014
17:25 EDTGRPNGroupon initiated with a Buy at Brean Capital
Subscribe for More Information
06:30 EDTPMPhilip Morris implied volatility of 15 at lower end of index mean range
October 20, 2014
16:14 EDTGRPNGroupon updates IPhone app to include Apple Pay
Subscribe for More Information
08:08 EDTIRWDIronwood presents IW-9179 Phase IIa clinical study data
Subscribe for More Information
October 17, 2014
09:59 EDTCMCSAComcast volatility elevated into Q3 and outlook
Subscribe for More Information
09:29 EDTCMCSAComcast it top large cap pick into the print, says Goldman
Goldman said Comcast is its top large cap pick into the earnings report given steady fundamentals, moderated expectations, and valuation. Shares are Buy rated with a $64 price target.
08:00 EDTCMCSAHBO may have fight with cable operators over OTT service price, Reuters says
Subscribe for More Information
October 16, 2014
15:10 EDTIRWDAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
08:02 EDTIRWDIronwood announces initiation of Phase II linaclotide trial
Ironwood Pharmaceuticals (IRWD) announced the initiation of a Phase II clinical trial evaluating linaclotide for the treatment of adults suffering from opioid-induced constipation. Data are expected in the second half of 2015. The clinical trial is being conducted jointly by Ironwood and Actavis plc (ACT), Ironwood’s co-development and co-promotion partner for linaclotide in the United States. Linaclotide is a guanylate cyclase-C agonist approved by the FDA for the treatment of adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Linaclotide is not currently approved for the treatment of OIC. The randomized, double-blind, placebo-controlled, multi-site Phase II clinical trial is expected to enroll approximately 240 adult patients with chronic, non-cancer pain who have been receiving a stable dose of an opioid analgesic and suffer from constipation, defined as fewer than three spontaneous bowel movements per week. Patients will be randomized to receive 145 mcg of linaclotide, 290 mcg of linaclotide, or placebo for eight weeks. The primary endpoint of the trial is an increase in SBM frequency. Additionally, a number of secondary endpoints and exploratory analyses intended to inform future development plans are included in the study design.
07:07 EDTPMPhilip Morris narrows 2014 adjusted EPS growth outlook to 6.5%-7.5%
Subscribe for More Information
07:04 EDTPMPhilip Morris reports adjusted Q3 EPS $1.39, consensus $1.33
Subscribe for More Information
October 15, 2014
16:00 EDTCMCSAOptions Update; October 15, 2014
Subscribe for More Information
15:28 EDTPMNotable companies reporting before tomorrow's open
Subscribe for More Information
07:27 EDTMOHModern Healthcare to hold a virtual conference
Building Tomorrow's Delivery Model: Forging a Path to Value is being held on October 15 at 9:30 am. Webcast Link
October 14, 2014
16:08 EDTMDUAvista 'quietly' seeks buyer, Berkshire interested, TheDeal.com says
Subscribe for More Information
14:01 EDTPMPhilip Morris October volatility elevated into Q3 and guidance
Subscribe for More Information
12:33 EDTZMHZimmer, Stryker have postive read-through from J&J, says Wells Fargo
Subscribe for More Information
11:11 EDTZMHJohnson & Johnson Ortho strength positive for Zimmer, says Piper Jaffray
Piper Jaffray said Johnson & Johnson's (JNJ) sequential Q3 strength in orthopedics, which included acceleration in both hips and knees, was surprising and a positive for Zimmer (ZMH). However, Piper expect sentiments on ortho names to remain muted until further into reporting season, noting that Stryker (SYK) is scheduled to report Thursday after the close. The firm has Neutral rating on Johnson & Johnson and Stryker and an Overweight rating on Zimmer.
October 13, 2014
06:32 EDTCMCSAUniversal receives approval to open $3.27B theme park in Beijing, WSJ reports
Subscribe for More Information
October 12, 2014
15:54 EDTCMCSA21st Century Fox's 'Gone Girl' wins at box office with $26.8M, Bloomberg says
21st Century Fox's (FOX, FOXA) “Gone Girl” took first place at the box office this weekend taking in $26.8M, says Bloomberg. "Dracula Untold,” from Comcast's (CMCSA) Universal Pictures came in second this weekend taking in $23.5M, added Bloomberg. Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use